机译:孟菲斯地区医院为实现华法林治疗的国家患者安全目标而开展的活动
College of Pharmacy, University of Tennessee, 910 Madison Avenue, Suite 322, Memphis, TN 38163;
Methodist University Hospital (MUH), Memphis;
Baptist Memorial Hospital (BMH), Memphis;
College of Pharmacy;
Anticoagulation/Surgery, The Regional Medical Center at Memphis, Memphis;
St. Jude Children's Research Hospital, Memphis;
LeBonheur Children's Medical Center (LBCMC), Memphis;
The Regional Medical Center at Memphis;
Department of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville Clinical Pharmacy Services, Department of Pharmacy, MUH;
Clinical Pharmacy and Pharmaceutical Sciences, College of Pharmacy College of Medicine, UT;
Veterans Affairs Medical Center, Memphis;
Saint Francis Hospital-Bartlett, Bartlett, TN;
Clinical Pharmacy Services, BMH;
administration; anticoagulants; hospitals; protocols; quality assurance; tennessee; toxicity; warfarin;
机译:原始规定执行符合华法林治疗国家患者安全目标的命令
机译:聚焦于医院的《 2016年国家患者安全目标》。
机译:准备使您的医院符合联合委员会的国家患者安全目标
机译:基于组的术语轨迹分析,用于高级患者的华法林治疗
机译:对美国儿科医院安全文化的看法:2016年医院患者安全文化调查的辅助数据分析
机译:遵守国家华法林治疗患者安全目标的命令集的执行
机译:2型糖尿病患者的心血管疾病风险,非肥胖患者和肥胖患者不符合葡萄糖和血压控制目标。瑞典国家糖尿病登记处报告